Sang Kook Lee Selected Research

Esters

1/2018	Coculture of Marine Streptomyces sp. With Bacillus sp. Produces a New Piperazic Acid-Bearing Cyclic Peptide.
2/2010	Daphnane diterpene esters with anti-proliferative activities against human lung cancer cells from Daphne genkwa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sang Kook Lee Research Topics

Disease

113	Neoplasms (Cancer) 02/2024 - 11/2002
26	Inflammation (Inflammations) 01/2023 - 01/2002
25	Colonic Neoplasms (Colon Cancer) 02/2024 - 01/2002
21	Lung Neoplasms (Lung Cancer) 12/2023 - 01/2003
19	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 09/2010
15	Neoplasm Metastasis (Metastasis) 01/2024 - 12/2005
15	Carcinogenesis 01/2024 - 01/2002
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 10/2011
10	Breast Neoplasms (Breast Cancer) 03/2024 - 05/2009
10	Triple Negative Breast Neoplasms 01/2023 - 12/2014
6	Fibrosarcoma 08/2012 - 11/2005
5	Edema (Dropsy) 01/2022 - 06/2007
5	Pneumonia (Pneumonitis) 07/2016 - 08/2013
5	Lung Diseases (Lung Disease) 02/2016 - 10/2013
5	Stomach Neoplasms (Stomach Cancer) 04/2015 - 09/2003
5	Body Weight (Weight, Body) 12/2012 - 02/2008
4	Hepatocellular Carcinoma (Hepatoma) 04/2021 - 02/2008
4	Leukemia 11/2016 - 09/2005
4	Acute Lung Injury 07/2016 - 09/2014
4	Bronchitis 09/2014 - 08/2013
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 07/2018
3	Infections 01/2022 - 07/2010
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 07/2013
3	Carcinoma (Carcinomatosis) 03/2015 - 05/2003
3	Acute Liver Failure (Fulminant Hepatic Failure) 11/2014 - 09/2014
2	Hematologic Neoplasms (Hematological Malignancy) 08/2023 - 01/2021
2	Osteoarthritis 01/2022 - 01/2016

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 05/2022 - 06/2007
10	AlkaloidsIBA 01/2022 - 01/2003
10	ErbB Receptors (EGF Receptor)IBA 04/2020 - 08/2011
9	Tyrosine Kinase InhibitorsIBA 01/2021 - 04/2015
9	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 12/2005
8	Gefitinib (Iressa)FDA Link 08/2023 - 11/2012
8	CateninsIBA 01/2022 - 08/2012
8	LipopolysaccharidesIBA 01/2019 - 01/2011
7	StilbenesIBA 02/2024 - 05/2003
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 09/2010
6	LignansIBA 01/2023 - 01/2008
6	DiterpenesIBA 09/2020 - 02/2010
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 01/2002
6	antofineIBA 04/2015 - 01/2003
5	Estrogen ReceptorsIBA 03/2024 - 05/2009
5	Cisplatin (Platino)FDA LinkGeneric 08/2023 - 02/2008
5	Docetaxel (Taxotere)FDA Link 01/2023 - 06/2016
5	MicroRNAs (MicroRNA)IBA 02/2019 - 01/2017
5	EnzymesIBA 06/2018 - 10/2007
5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2017 - 03/2012
5	MucinsIBA 02/2016 - 01/2014
5	phenanthroindolizidineIBA 04/2015 - 01/2003
5	Matrix Metalloproteinases (MMPs)IBA 12/2012 - 12/2005
4	Gemcitabine FDA Link 01/2024 - 11/2012
4	CytokinesIBA 01/2023 - 01/2014
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 11/2010
4	CarrageenanIBA 01/2022 - 08/2010
4	LigandsIBA 03/2018 - 01/2011
4	mezereinIBA 01/2015 - 02/2010
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2012 - 12/2005
4	Purinergic P1 Receptors (Adenosine Receptor)IBA 09/2011 - 09/2005
4	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2011 - 10/2004
4	ProstaglandinsIBA 12/2010 - 01/2002
4	ResveratrolIBA 10/2004 - 04/2003
3	Histones (Histone)IBA 06/2023 - 12/2019
3	shinbaroIBA 01/2023 - 08/2010
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2023 - 04/2021
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 09/2009
3	NucleosidesIBA 01/2021 - 12/2018
3	Cyclin D1IBA 02/2020 - 02/2008
3	Biomarkers (Surrogate Marker)IBA 12/2019 - 06/2014
3	GalactosamineIBA 11/2014 - 09/2014
3	TriterpenesIBA 11/2014 - 02/2008
3	FlavonoidsIBA 11/2014 - 08/2004
3	Expectorants (Mucolytics)IBA 09/2014 - 01/2014
3	pinosylvinIBA 05/2013 - 12/2004
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2012 - 06/2007
3	thio-Cl-IB-MECAIBA 09/2011 - 09/2005
3	Adenosine (Adenocard)FDA LinkGeneric 09/2011 - 09/2005
3	lissamine rhodamine B (sulforhodamine B)IBA 04/2008 - 01/2007
3	Peptide Hydrolases (Proteases)FDA Link 05/2006 - 12/2005
3	ZincIBA 05/2006 - 12/2005
3	Messenger RNA (mRNA)IBA 05/2006 - 12/2005
3	indoleIBA 12/2005 - 09/2003
2	flavanoneIBA 02/2024 - 08/2004
2	Purinergic P1 Receptor AntagonistsIBA 01/2024 - 01/2023
2	piceamycinIBA 01/2024 - 12/2022
2	Dacarbazine (DIC)FDA LinkGeneric 08/2023 - 11/2011
2	Temozolomide (Temodar)FDA LinkGeneric 08/2023 - 03/2023
2	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 06/2016
2	Histamine (Histamine Dihydrochloride)FDA Link 09/2022 - 01/2016
2	NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)IBA 04/2021 - 08/2004
2	pulvomycinIBA 04/2021 - 01/2020
2	benzophenoneIBA 01/2021 - 02/2020
2	Oxygen (Dioxygen)IBA 01/2021 - 11/2015
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2020 - 11/2012
2	TubulinIBA 02/2020 - 06/2016
2	neplanocin AIBA 01/2020 - 11/2004
2	AdenosylhomocysteinaseIBA 01/2020 - 07/2018
2	CarcinogensIBA 10/2018 - 01/2011

Therapy/Procedure

12	Therapeutics 10/2021 - 07/2010
9	Drug Therapy (Chemotherapy) 01/2023 - 01/2006
6	Oral Administration 01/2016 - 08/2010